Published by Iain Gilbert on 3rd November 2022
(Sharecast News) - Drugmaker Hikma Pharmaceuticals reiterated full-year guidance on Thursday, citing "strong momentum" in its injectables and branded units, but also cautioned that had begun to see the effects of the global inflationary environment on costs.
URL: http://www.digitallook.com/dl/news/story/33082237/...